This is supported by the inclusion of Wesley Nicolas, an in-house counsel at Novo Nordisk, among the top listed representatives
Originally developed for managing type 2 diabetes, Semaglutide GLP-1 has also gained approval for weight management in certain individuals, making it a versatile tool in the pursuit of overall well-being
Final pricing is confirmed during your consultation
NICE guidance including Technology Appraisal TA875 (semaglutide 2.4 mg for managing overweight and obesity), Clinical Guideline CG189 (Obesity: identification, assessment and management), and Public Health Guidance PH53 (Weight management: lifestyle services for overweight or obese adults) recommends a structured, tiered approach to weight management
These findings are comforting as clinicians can now safely use these agents in patients with metabolic syndrome and those at a higher cardiovascular risk
Specific forms of cancer are seen at a higher incidence and are associated with poorer survival rate in obese patients, including colorectal, breast, kidney, esophageal adenocarcinoma, endometrial and gallbladder cancer , [12] , [13]
